Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
H. Woehrle (Ulm, Germany), M. Cowie (London, United Kingdom), K. Wegscheider (Hamburg, Germany), C. Angermann (Würzburg, Germany), M. D'Ortho (Paris, France), E. Erdmann (Cologne, Germany), P. Levy (Grenoble, France), A. Simonds (London, United Kingdom), V. Somers (Rochester, United States of America), F. Zannad (Nancy, France), H. Teschler (Essen, Germany), E. Vettorazzi (Hamburg, Germany). Association between symptomatic improvements and outcome: responder analysis of SERVE-HF. 4160

Member's Comments

No comment yet.

Related content which might interest you: Disease awareness in COPD: Analyses of clinical parameters and patient-reported outcome from the SAT study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Association between patient-reported outcomes and exercise test outcomes in patients with COPD. Source: Virtual Congress 2020 – New insights into determinants of patient-reported outcomes in chronic respiratory diseases Year: 2020 Examination of variations in responder rates in COPD clinical trial outcomes Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Determinants of long-term changes in ADO prognostic score in UK COPD primary care patients: results from The Health Improvement Network Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019 REG endpoint validation: Do database asthma control measures predict future risk? Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014 Late Breaking Abstract - Early benefits in patient-reported outcomes (PROs) and physical activity (PA) in patients with severe eosinophilic asthma (SEA) treated with benralizumab: interim analysis of the imPROve Asthma study Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Association between patient-reported outcomes and functional test outcomes in patients with COPD before undergoing home-based pulmonary rehabilitation. Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19 Year: 2021 Association between age and clinical characteristics and outcomes of COVID-19 Source: Eur Respir J, 55 (5) 2001112; 10.1183/13993003.01112-2020 Year: 2020 Simple functional performance tests as predictors of clinical outcomes in COPD Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 REG endpoint validation: Association between database and patient-reported exacerbations Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Prognostic value of clinically important deterioration in COPD: IMPACT trial analysis Source: ERJ Open Res, 7 (1) 00663-2020; 10.1183/23120541.00663-2020 Year: 2021 Methodology of clinical trials in COPD exacerbations: Eligibility criteria and endpoint selection. Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 Clinical trials and outcome measures Source: School Course 2013 - Primary ciliary dyskinesia: sharing knowledge and experience across Europe Year: 2013 Clinical outcome and cost-effectiveness of 1-year nutritional intervention program in COPD Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Observational study to characterise 24-hour COPD symptoms: Interim analysis of ASSESS Source: Annual Congress 2013 –Monitoring symptoms and quality of life Year: 2013